{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:47:58Z","timestamp":1792752478360,"version":"4.5.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>von Willebrand disease (VWD) type 1 is difficult to diagnose because of bleeding variability and low heritability of von Willebrand factor (VWF) levels. We compared a bleeding severity score and bleeding times to candidate gene haplotypes within pedigrees of 14 index cases, using a covariance components model for multivariate traits (Mendel: QTL Association). These pedigrees included 13 affected and 40 unaffected relatives, as defined by plasma ristocetin cofactor (VWF:RCo) levels. The bleeding severity score was derived from a detailed history. Donors were genotyped using a primer extension method, and 9 candidate genes were selected for analysis. VWF:RCo levels had the strongest influence on bleeding severity score and bleeding time. ITGA2 haplotype 2 (807C) and ITGA2B haplotype 1 (Ile843) were each associated with increased bleeding severity scores (P &amp;lt; .01 and P &amp;lt; .01, respectively). GP6 haplotype b (Pro219) was also associated with increased scores (P = .03) after adjustment for donor age. No association was observed with 6 other candidate genes, GP1BA, ITGB3, VWF, FGB, IL6, or TXA2R. Increased plasma VWF:Ag levels were associated with VWF haplotype 1 (\u20131793G; P = .02). These results establish that genetic differences in the adhesion receptor subunits \u03b12, \u03b1IIb, and GPVI can influence the phenotype of VWD type 1.<\/jats:p>","DOI":"10.1182\/blood-2004-01-0349","type":"journal-article","created":{"date-parts":[[2004,6,30]],"date-time":"2004-06-30T00:53:31Z","timestamp":1088556811000},"page":"2359-2367","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":55,"title":["An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees"],"prefix":"10.1182","volume":"104","author":[{"given":"Thomas J.","family":"Kunicki","sequence":"first","affiliation":[{"name":"From the Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Division of Biostatistics of the Department of Molecular and Experimental Medicine, and the DNA Array Core Facility of The Scripps Research Institute, La Jolla, CA; Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital and University of Milan, Italy; and Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto B.","family":"Federici","sequence":"additional","affiliation":[{"name":"From the Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Division of Biostatistics of the Department of Molecular and Experimental Medicine, and the DNA Array Core Facility of The Scripps Research Institute, La Jolla, CA; Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital and University of Milan, Italy; and Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Salomon","sequence":"additional","affiliation":[{"name":"From the Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Division of Biostatistics of the Department of Molecular and Experimental Medicine, and the DNA Array Core Facility of The Scripps Research Institute, La Jolla, CA; Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital and University of Milan, Italy; and Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Koziol","sequence":"additional","affiliation":[{"name":"From the Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Division of Biostatistics of the Department of Molecular and Experimental Medicine, and the DNA Array Core Facility of The Scripps Research Institute, La Jolla, CA; Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital and University of Milan, Italy; and Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Head","sequence":"additional","affiliation":[{"name":"From the Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Division of Biostatistics of the Department of Molecular and Experimental Medicine, and the DNA Array Core Facility of The Scripps Research Institute, La Jolla, CA; Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital and University of Milan, Italy; and Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony S.","family":"Mondala","sequence":"additional","affiliation":[{"name":"From the Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Division of Biostatistics of the Department of Molecular and Experimental Medicine, and the DNA Array Core Facility of The Scripps Research Institute, La Jolla, CA; Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital and University of Milan, Italy; and Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Chismar","sequence":"additional","affiliation":[{"name":"From the Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Division of Biostatistics of the Department of Molecular and Experimental Medicine, and the DNA Array Core Facility of The Scripps Research Institute, La Jolla, CA; Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital and University of Milan, Italy; and Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Baronciani","sequence":"additional","affiliation":[{"name":"From the Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Division of Biostatistics of the Department of Molecular and Experimental Medicine, and the DNA Array Core Facility of The Scripps Research Institute, La Jolla, CA; Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital and University of Milan, Italy; and Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Canciani","sequence":"additional","affiliation":[{"name":"From the Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Division of Biostatistics of the Department of Molecular and Experimental Medicine, and the DNA Array Core Facility of The Scripps Research Institute, La Jolla, CA; Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital and University of Milan, Italy; and Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Peake","sequence":"additional","affiliation":[{"name":"From the Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Division of Biostatistics of the Department of Molecular and Experimental Medicine, and the DNA Array Core Facility of The Scripps Research Institute, La Jolla, CA; Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital and University of Milan, Italy; and Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218210461700_REF1","doi-asserted-by":"crossref","unstructured":"Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94: 657-666.","DOI":"10.1016\/S0092-8674(00)81607-4"},{"key":"2020021218210461700_REF2","doi-asserted-by":"crossref","unstructured":"Kunicki TJ. The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol. 2002;22: 14-20.","DOI":"10.1161\/hq0102.100458"},{"key":"2020021218210461700_REF3","doi-asserted-by":"crossref","unstructured":"Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood. 2003;101: 2089-2093.","DOI":"10.1182\/blood-2002-09-2892"},{"key":"2020021218210461700_REF4","unstructured":"Castaman G, Federici AB, Rodeghiero F, Mannucci PM. von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica. 2003;88: 94-108."},{"key":"2020021218210461700_REF5","doi-asserted-by":"crossref","unstructured":"Murata M, Furihata K, Ishida F, et al. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Iba involved in platelet transfusion refractoriness. Blood. 1992;79: 3086-3090.","DOI":"10.1182\/blood.V79.11.3086.3086"},{"key":"2020021218210461700_REF6","doi-asserted-by":"crossref","unstructured":"Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, Lopez JA. Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood. 1999;94: 186-191.","DOI":"10.1182\/blood.V94.1.186.413k19_186_191"},{"key":"2020021218210461700_REF7","doi-asserted-by":"crossref","unstructured":"Croft SA, Samani NJ, Teare MD, et al. Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation. 2001;104: 1459-1463.","DOI":"10.1161\/hc3801.096397"},{"key":"2020021218210461700_REF8","doi-asserted-by":"crossref","unstructured":"Kritzik M, Savage B, Nugent DJ, et al. Nucleotide polymorphisms in the alpha 2 gene define multiple alleles which are associated with differences in platelet alpha 2 beta 1. Blood. 1998;92: 2382-2388.","DOI":"10.1182\/blood.V92.7.2382"},{"key":"2020021218210461700_REF9","doi-asserted-by":"crossref","unstructured":"Reiner AP, Kumar PN, Schwartz SM, et al. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke. 2000; 31: 1628-1633.","DOI":"10.1161\/01.STR.31.7.1628"},{"key":"2020021218210461700_REF10","doi-asserted-by":"crossref","unstructured":"Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PLA1 and PLA2, are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest. 1989;83: 1778-1781.","DOI":"10.1172\/JCI114082"},{"key":"2020021218210461700_REF11","doi-asserted-by":"crossref","unstructured":"Moshfegh K, Wuillemin WA, Redondo M, et al. Association of two silent polymorphisms of platelet glycoprotein Ia\/IIa receptor with risk of myocardial infarction: a case-control study. Lancet. 1999;353: 351-354.","DOI":"10.1016\/S0140-6736(98)06448-4"},{"key":"2020021218210461700_REF12","doi-asserted-by":"crossref","unstructured":"Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A. Association of the platelet glycoprotein Ia C807T gene polymorphism with myocardial infarction in younger patients. Blood. 1999;93: 2449-2453.","DOI":"10.1182\/blood.V93.8.2449"},{"key":"2020021218210461700_REF13","doi-asserted-by":"crossref","unstructured":"Roest M, Banga JD, Grobbee DE, et al. Homozygosity for 807 T polymorphism in alpha(2) subunit of platelet alpha(2)beta(1) is associated with increased risk of cardiovascular mortality in highrisk women. Circulation. 2000;102: 1645-1650.","DOI":"10.1161\/01.CIR.102.14.1645"},{"key":"2020021218210461700_REF14","doi-asserted-by":"crossref","unstructured":"Matsubara Y, Murata M, Maruyama T, et al. Association between diabetic retinopathy and genetic variations in alpha-2 beta-1 integrin, a platelet receptor for collagen. Blood. 2000;95: 1560-1564.","DOI":"10.1182\/blood.V95.5.1560.005k43_1560_1564"},{"key":"2020021218210461700_REF15","doi-asserted-by":"crossref","unstructured":"Carlsson LE, Santoso S, Spitzer C, Kessler C, Greinacher A. The alpha 2 gene coding sequences T807\/A873 of the platelet collagen receptor integrin alpha2 beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood. 1999;93: 3583-3586.","DOI":"10.1182\/blood.V93.11.3583"},{"key":"2020021218210461700_REF16","doi-asserted-by":"crossref","unstructured":"Joutsi-Korhonen L, Smethurst PA, Rankin A, et al. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood. 2003;101: 4372-4379.","DOI":"10.1182\/blood-2002-08-2591"},{"key":"2020021218210461700_REF17","doi-asserted-by":"crossref","unstructured":"Carter AM, Catto AJ, Bamford JM, Grant PJ. Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke. Stroke. 1999;30: 2606-2611.","DOI":"10.1161\/01.STR.30.12.2606"},{"key":"2020021218210461700_REF18","doi-asserted-by":"crossref","unstructured":"Carlsson LE, Greinacher A, Spitzer C, Walther R, Kessler C. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb\/IIIa), von Willebrand factor (GPIb\/IX), and collagen (GPIa\/IIa) are not correlated with an increased risk for stroke. Stroke. 1997;28: 1392-1395.","DOI":"10.1161\/01.STR.28.7.1392"},{"key":"2020021218210461700_REF19","doi-asserted-by":"crossref","unstructured":"Bottiger C, Kastrati A, Koch W, et al. HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost. 2000; 83: 559-562.","DOI":"10.1055\/s-0037-1613863"},{"key":"2020021218210461700_REF20","doi-asserted-by":"crossref","unstructured":"Keightley AM, Lam YM, Brady JN, Cameron CL, Lillicrap D. Variation at the von Willebrand Factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood. 1999;93: 4277-4283.","DOI":"10.1182\/blood.V93.12.4277"},{"key":"2020021218210461700_REF21","doi-asserted-by":"crossref","unstructured":"Brull DJ, Dhamrait S, Moulding R, et al. The effect of fibrinogen genotype on fibrinogen levels after strenuous physical exercise. Thromb Haemost. 2002;87: 37-41.","DOI":"10.1055\/s-0037-1612940"},{"key":"2020021218210461700_REF22","doi-asserted-by":"crossref","unstructured":"Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6\u2013174 G\/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J. 2001;22: 2243-2252.","DOI":"10.1053\/euhj.2001.2678"},{"key":"2020021218210461700_REF23","doi-asserted-by":"crossref","unstructured":"Unoki M, Furuta S, Onouchi Y, et al. Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene. Hum Genet. 2000;106: 440-446.","DOI":"10.1007\/s004390000267"},{"key":"2020021218210461700_REF24","doi-asserted-by":"crossref","unstructured":"Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 1994;71: 520-525.","DOI":"10.1055\/s-0038-1642471"},{"key":"2020021218210461700_REF25","doi-asserted-by":"crossref","unstructured":"Federici AB, Stabile F, Castaman G, Canciani MT, Mannucci PM. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood. 1998;92: 2707-2711.","DOI":"10.1182\/blood.V92.8.2707"},{"key":"2020021218210461700_REF26","doi-asserted-by":"crossref","unstructured":"Kunicki TJ, Head SR, Salomon DR. Platelet receptor structures and polymorphisms. In: Gibbins J.M., Mahaut-Smith MP, eds. Platelets and Megakaryocytes. Methods and Protocols. Totowa, NJ: Humana Press; 2003: 455-478.","DOI":"10.1385\/1-59259-783-1:455"},{"key":"2020021218210461700_REF27","doi-asserted-by":"crossref","unstructured":"Lange K, Boehnke M. Extensions to pedigree analysis, IV: covariance components models for multivariate traits. Am J Med Genet. 1983;14: 513-524.","DOI":"10.1002\/ajmg.1320140315"},{"key":"2020021218210461700_REF28","unstructured":"Lange K, Cantor R, Horvath S, et al. Mendel version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets [abstract]. Am J Hum Genet. 2001;69: A1886."},{"key":"2020021218210461700_REF29","doi-asserted-by":"crossref","unstructured":"Di Paola J, Federici AB, Sacchi E, et al. Low platelet alpha 2 beta 1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood. 1999;93: 3578-3582.","DOI":"10.1182\/blood.V93.11.3578"},{"key":"2020021218210461700_REF30","doi-asserted-by":"crossref","unstructured":"Blangero J, Williams JT, Almasy L. Novel familybased approaches to genetic risk in thrombosis. J Thromb Haemost. 2003;1: 1391-1397.","DOI":"10.1046\/j.1538-7836.2003.00310.x"},{"key":"2020021218210461700_REF31","doi-asserted-by":"crossref","unstructured":"Umbach DM, Weinberg CR. The use of case-parent triads to study joint effects of genotype and exposure. Am J Hum Genet. 2000;66: 251-261.","DOI":"10.1086\/302707"},{"key":"2020021218210461700_REF32","doi-asserted-by":"crossref","unstructured":"Risch N. Implications of multilocus inheritance for gene-disease association studies. Theor Popul Biol. 2001;60: 215-220.","DOI":"10.1006\/tpbi.2001.1538"},{"key":"2020021218210461700_REF33","doi-asserted-by":"crossref","unstructured":"Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987;69: 1691-1695.","DOI":"10.1182\/blood.V69.6.1691.1691"},{"key":"2020021218210461700_REF34","doi-asserted-by":"crossref","unstructured":"Orstavik KH, Kornstad L, Reisner H, Berg K. Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor. Blood. 1989;73: 990-993.","DOI":"10.1182\/blood.V73.4.990.990"},{"key":"2020021218210461700_REF35","doi-asserted-by":"crossref","unstructured":"Kato K, Kanaji T, Russell S, et al. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood. 2003;102: 1701-1707.","DOI":"10.1182\/blood-2003-03-0717"},{"key":"2020021218210461700_REF36","doi-asserted-by":"crossref","unstructured":"Chen J, Diacovo TG, Grenache DG, Santoro SA, Zutter MM. The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol. 2002;161: 337-344.","DOI":"10.1016\/S0002-9440(10)64185-5"},{"key":"2020021218210461700_REF37","doi-asserted-by":"crossref","unstructured":"Li TT, Larrucea S, Souza S, et al. Genetic variation responsible for mouse strain differences in integrin (alpha)2 expression is associated with altered platelet responses to collagen. Blood. 2004;103: 3396-3402.","DOI":"10.1182\/blood-2003-10-3721"},{"key":"2020021218210461700_REF38","doi-asserted-by":"crossref","unstructured":"Lyman S, Aster RH, Visentin GP, Newman PJ. Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka\/Bakb alloantigen system. Blood. 1990;75: 2343-2348.","DOI":"10.1182\/blood.V75.12.2343.2343"},{"key":"2020021218210461700_REF39","doi-asserted-by":"crossref","unstructured":"Shadle PJ, Ginsberg MH, Plow EF, Barondes SH. Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb. J Cell Biol. 1984;99: 2056-2060.","DOI":"10.1083\/jcb.99.6.2056"},{"key":"2020021218210461700_REF40","doi-asserted-by":"crossref","unstructured":"Frelinger AL III, Lam SC-T, Plow EF. et al. Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem. 1988;263: 12397-12402.","DOI":"10.1016\/S0021-9258(18)37769-X"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/8\/2359\/1702601\/zh802004002359.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/8\/2359\/1702601\/zh802004002359.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T21:26:32Z","timestamp":1624483592000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/8\/2359\/19090\/An-association-of-candidate-gene-haplotypes-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,15]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-01-0349","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,15]]}}}